Translation of rare disease research into orphan drug development: disease matters

Area of Science:

• Medical Science
• Pharmacology
• Rare Diseases

Background:

• Over 25 years of orphan drug regulations have led to new treatments for rare diseases.
• However, the success of translating research into drug development varies.
• Factors influencing this translation are not fully understood.

Purpose of the Study:

• To investigate the factors determining successful translation of rare disease research into orphan drug discovery and development programs.
• To assess the sufficiency of current orphan drug legislation in stimulating development for all rare diseases.

Main Methods:

• Analysis of rare disease research translation into drug development programs.
• Evaluation of the impact of disease class, prevalence, and scientific output.
• Assessment of current orphan drug legislation effectiveness.

Main Results:

• Successful translation is significantly dependent on disease class, prevalence, and scientific output.
• Current orphan drug legislation is insufficient to stimulate development for diseases with very low prevalence.
• Disease-specific research needs require tailored incentives.

Conclusions:

• Orphan drug legislation alone is not enough to drive development for all rare diseases, especially those with very low prevalence.
• Additional, targeted incentives are necessary to stimulate rare disease research at the disease class level.
• Future strategies must address the specific needs of different rare disease categories.